A longitudinal study of the metabolic syndrome and risk of colorectal cancer in postmenopausal women

Geoffrey C. Kabat, Mimi Kim, Ulrike Peters, Marcia Stefanick, Lifang Hou, Jean Wactawski-Wende, Catherine Messina, James M. Shikany, Thomas E. Rohan

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

The metabolic syndrome is associated with increased risk of diabetes and coronary heart disease. Although higher BMI and other related factors have been frequently associated with colorectal cancer, whether the metabolic syndrome is associated with the risk of colorectal cancer is unclear. We therefore assessed the association of the metabolic syndrome with the risk of colorectal cancer in a subsample of participants of the Women's Health Initiative who had repeated measurements of the components of the syndrome at baseline and during follow-up. Women with diabetes at baseline enrollment were excluded. Cox proportional hazards models were used to estimate hazard ratios (HRs) and 95% confidence intervals (95% CI) at baseline and in time-dependent analyses. Among 4862 eligible women, 81 incident cases of colorectal cancer were identified over a median follow-up of 12 years. Presence of the metabolic syndrome at baseline was associated with increased risk of colorectal cancer (HR 2.15, 95% CI 1.30-3.53) and colon cancer (HR 2.28, 95% CI 1.31-3.98). These associations were largely explained by positive associations of serum glucose and systolic blood pressure with both outcomes. Time-dependent covariate analyses supported the baseline findings. Our results suggest that the positive association of the metabolic syndrome with risk of colorectal cancer is largely accounted for by serum glucose levels and systolic blood pressure. The biological mechanism underlying these associations remains to be clarified.

Original languageEnglish (US)
Pages (from-to)326-332
Number of pages7
JournalEuropean Journal of Cancer Prevention
Volume21
Issue number4
DOIs
StatePublished - Jul 2012

Fingerprint

Longitudinal Studies
Colorectal Neoplasms
Blood Pressure
Confidence Intervals
Glucose
Women's Health
Serum
Proportional Hazards Models
Colonic Neoplasms
Coronary Disease

Keywords

  • colorectal cancer
  • hyperinsulinemia
  • hypertension
  • insulin resistance
  • metabolic syndrome
  • obesity
  • postmenopausal women
  • time-dependent covariates

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Epidemiology
  • Public Health, Environmental and Occupational Health

Cite this

A longitudinal study of the metabolic syndrome and risk of colorectal cancer in postmenopausal women. / Kabat, Geoffrey C.; Kim, Mimi; Peters, Ulrike; Stefanick, Marcia; Hou, Lifang; Wactawski-Wende, Jean; Messina, Catherine; Shikany, James M.; Rohan, Thomas E.

In: European Journal of Cancer Prevention, Vol. 21, No. 4, 07.2012, p. 326-332.

Research output: Contribution to journalArticle

Kabat, Geoffrey C. ; Kim, Mimi ; Peters, Ulrike ; Stefanick, Marcia ; Hou, Lifang ; Wactawski-Wende, Jean ; Messina, Catherine ; Shikany, James M. ; Rohan, Thomas E. / A longitudinal study of the metabolic syndrome and risk of colorectal cancer in postmenopausal women. In: European Journal of Cancer Prevention. 2012 ; Vol. 21, No. 4. pp. 326-332.
@article{b3bdc4c46a15470bafae0484e994952c,
title = "A longitudinal study of the metabolic syndrome and risk of colorectal cancer in postmenopausal women",
abstract = "The metabolic syndrome is associated with increased risk of diabetes and coronary heart disease. Although higher BMI and other related factors have been frequently associated with colorectal cancer, whether the metabolic syndrome is associated with the risk of colorectal cancer is unclear. We therefore assessed the association of the metabolic syndrome with the risk of colorectal cancer in a subsample of participants of the Women's Health Initiative who had repeated measurements of the components of the syndrome at baseline and during follow-up. Women with diabetes at baseline enrollment were excluded. Cox proportional hazards models were used to estimate hazard ratios (HRs) and 95{\%} confidence intervals (95{\%} CI) at baseline and in time-dependent analyses. Among 4862 eligible women, 81 incident cases of colorectal cancer were identified over a median follow-up of 12 years. Presence of the metabolic syndrome at baseline was associated with increased risk of colorectal cancer (HR 2.15, 95{\%} CI 1.30-3.53) and colon cancer (HR 2.28, 95{\%} CI 1.31-3.98). These associations were largely explained by positive associations of serum glucose and systolic blood pressure with both outcomes. Time-dependent covariate analyses supported the baseline findings. Our results suggest that the positive association of the metabolic syndrome with risk of colorectal cancer is largely accounted for by serum glucose levels and systolic blood pressure. The biological mechanism underlying these associations remains to be clarified.",
keywords = "colorectal cancer, hyperinsulinemia, hypertension, insulin resistance, metabolic syndrome, obesity, postmenopausal women, time-dependent covariates",
author = "Kabat, {Geoffrey C.} and Mimi Kim and Ulrike Peters and Marcia Stefanick and Lifang Hou and Jean Wactawski-Wende and Catherine Messina and Shikany, {James M.} and Rohan, {Thomas E.}",
year = "2012",
month = "7",
doi = "10.1097/CEJ.0b013e32834dbc81",
language = "English (US)",
volume = "21",
pages = "326--332",
journal = "European Journal of Cancer Prevention",
issn = "0959-8278",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - A longitudinal study of the metabolic syndrome and risk of colorectal cancer in postmenopausal women

AU - Kabat, Geoffrey C.

AU - Kim, Mimi

AU - Peters, Ulrike

AU - Stefanick, Marcia

AU - Hou, Lifang

AU - Wactawski-Wende, Jean

AU - Messina, Catherine

AU - Shikany, James M.

AU - Rohan, Thomas E.

PY - 2012/7

Y1 - 2012/7

N2 - The metabolic syndrome is associated with increased risk of diabetes and coronary heart disease. Although higher BMI and other related factors have been frequently associated with colorectal cancer, whether the metabolic syndrome is associated with the risk of colorectal cancer is unclear. We therefore assessed the association of the metabolic syndrome with the risk of colorectal cancer in a subsample of participants of the Women's Health Initiative who had repeated measurements of the components of the syndrome at baseline and during follow-up. Women with diabetes at baseline enrollment were excluded. Cox proportional hazards models were used to estimate hazard ratios (HRs) and 95% confidence intervals (95% CI) at baseline and in time-dependent analyses. Among 4862 eligible women, 81 incident cases of colorectal cancer were identified over a median follow-up of 12 years. Presence of the metabolic syndrome at baseline was associated with increased risk of colorectal cancer (HR 2.15, 95% CI 1.30-3.53) and colon cancer (HR 2.28, 95% CI 1.31-3.98). These associations were largely explained by positive associations of serum glucose and systolic blood pressure with both outcomes. Time-dependent covariate analyses supported the baseline findings. Our results suggest that the positive association of the metabolic syndrome with risk of colorectal cancer is largely accounted for by serum glucose levels and systolic blood pressure. The biological mechanism underlying these associations remains to be clarified.

AB - The metabolic syndrome is associated with increased risk of diabetes and coronary heart disease. Although higher BMI and other related factors have been frequently associated with colorectal cancer, whether the metabolic syndrome is associated with the risk of colorectal cancer is unclear. We therefore assessed the association of the metabolic syndrome with the risk of colorectal cancer in a subsample of participants of the Women's Health Initiative who had repeated measurements of the components of the syndrome at baseline and during follow-up. Women with diabetes at baseline enrollment were excluded. Cox proportional hazards models were used to estimate hazard ratios (HRs) and 95% confidence intervals (95% CI) at baseline and in time-dependent analyses. Among 4862 eligible women, 81 incident cases of colorectal cancer were identified over a median follow-up of 12 years. Presence of the metabolic syndrome at baseline was associated with increased risk of colorectal cancer (HR 2.15, 95% CI 1.30-3.53) and colon cancer (HR 2.28, 95% CI 1.31-3.98). These associations were largely explained by positive associations of serum glucose and systolic blood pressure with both outcomes. Time-dependent covariate analyses supported the baseline findings. Our results suggest that the positive association of the metabolic syndrome with risk of colorectal cancer is largely accounted for by serum glucose levels and systolic blood pressure. The biological mechanism underlying these associations remains to be clarified.

KW - colorectal cancer

KW - hyperinsulinemia

KW - hypertension

KW - insulin resistance

KW - metabolic syndrome

KW - obesity

KW - postmenopausal women

KW - time-dependent covariates

UR - http://www.scopus.com/inward/record.url?scp=84861807742&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861807742&partnerID=8YFLogxK

U2 - 10.1097/CEJ.0b013e32834dbc81

DO - 10.1097/CEJ.0b013e32834dbc81

M3 - Article

VL - 21

SP - 326

EP - 332

JO - European Journal of Cancer Prevention

JF - European Journal of Cancer Prevention

SN - 0959-8278

IS - 4

ER -